The importance of the false-negative rate to validate a staging protocol for non-small cell lung cancer

Carme Obiols, Sergi Call, Ramon Rami-Porta


First of all, we would like to congratulate Dr. Verdial et al. for their recently published article entitled “A prediction model for nodal disease among patients with non-small cell lung cancer” (1). Dr. Verdial and co-workers have analyzed their experience in mediastinal nodal staging for non-small cell lung cancer (NSCLC), based on the recommendations of the current guidelines, in order to find out a better model to predict nodal disease and reduce the need of invasive staging procedures.